What is the term used to identify when the meatal opening is located on the dorsal surface of the penis?

The correct answer is choice C. Activity intolerance related to generalized weakness.

Choice A rationale:

Risk for injury related to depressed sensorium. This choice is not the most appropriate nursing diagnosis for a child with moderate anemia. While anemia can lead to fatigue and weakness, the main concern is the child's ability to tolerate physical activities, not the risk of injury due to a depressed sensorium.

Choice B rationale:

Decreased cardiac output related to abnormal hemoglobin. This choice is not the most suitable nursing diagnosis for a child with moderate anemia. While abnormal hemoglobin levels can affect cardiac output, moderate anemia typically doesn't lead to such a significant decrease in cardiac output that it becomes the primary nursing diagnosis. Activity intolerance is a more relevant concern.

Choice C rationale:

Activity intolerance related to generalized weakness. This is the most appropriate nursing diagnosis for a child diagnosed with moderate anemia. Moderate anemia results in a decrease in oxygen-carrying capacity, leading to generalized weakness and reduced ability to perform physical activities without becoming fatigued. The child's hemoglobin levels are likely low enough to cause noticeable activity intolerance.

Choice D rationale:

Risk for Injury related to dehydration and abnormal hemoglobin. This choice is not the best nursing diagnosis for a child with moderate anemia. Dehydration may exacerbate the effects of anemia, but the primary issue here is the anemia itself causing weakness and activity intolerance, which are better addressed with the choice C diagnosis.

The correct answers are choices C. Novolin R, and D. NovoLog.

Choice A rationale:

Novolin N is an intermediate-acting insulin, not rapid or short acting. It has a slower onset and longer duration of action, making it unsuitable for rapid blood sugar control.

Choice B rationale:

Lantus is a long-acting insulin that provides basal insulin coverage and has a relatively steady effect over 24 hours. It is not rapid or short acting and is used to provide a baseline level of insulin, not for immediate blood sugar control.

Choice C rationale:

Novolin R, also known as regular insulin, is a short-acting insulin with an onset of about 30 minutes and a peak effect around 2 to 3 hours. It is often used to cover mealtime blood sugar elevations and is suitable for short-term blood sugar control.

Choice D rationale:

NovoLog is a rapid-acting insulin analog with an onset of about 15 minutes and a peak effect within 1 to 2 hours. It is designed to mimic the body's rapid insulin release after meals, making it effective for controlling postprandial blood sugar levels.